All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

DecisionRx, a value-based care medication management platform, received a $100 million credit facility from Carlyle, DecisionRx CEO James Wallace tells Axios exclusively. 

Why it matters: Medication failure can cost health systems up to $42 billion annually while health care spend continues to increase. 

Details: This transaction was led by Carlyle's Credit Strategic Solutions, a group within the Global Credit business focused on private fixed income and asset-backed investments. 

Carlyle receives the option to acquire 25% of the outstanding equity of DecisionRx. Aon Securities advised DecisionRx. 

The revenue model comes from value-based care models, that uses Medicare shared savings program.

The cost of putting the patient through Medication Therapy Optimization and payment for the clinician is paid for up front, by DecisionRx using funds from the credit facility. 

There is an option to expand or extend the facility with more money, if needed. 

How it works: DecisionRx's " concierge-pharmacists" make personalized medication recommendations to prescribers (physicians and pharmacists), based on genetic profiles, existing medication regimes and contraindications.

What they're saying: "We like to lend against pools of assets that have contractual cash flows," says Akhil Bansal, head of credit strategic solutions at Carlyle.

"There is a lot of focus right now on lower costs for drugs but this takes a step back into the root causes," he adds. 

What's next: The company is targeting prospects that include insurers and ACO's, as well as strategic retail players such as Amazon, CVS and Walgreens, and large self-funded employers, he says.

"Health care is a huge blue ocean," he says. "[From]" Medicare all the way down to the smallest employer will benefit from precision medicine."

Exclusive: DecisionRx nets $100M credit facility from Carlyle

Medication failure can cost health systems up to $42 billion annually

Illustration of a hand cursor pointing at a bottle of prescription pills. 

Health tech deals

DecisionRx, a value-based care medication management platform, received a $100 million credit facility from Carlyle, DecisionRx CEO James Wallace tells Axios exclusively. Why it matters: Medication failure can cost health systems up to <a class="gtmContentClick" data-vars-link-text="$42 billion annually " data-vars-click-url="https://www.who.int/initiatives/medication-without-harm#:~:text=Unsafe%20medication%20practices%20and%20medication,at%20%2442%20billion%20USD%20annually." data-vars-content-id="e1678b9e-f9ce-430d-9505-cb8eef28f864" data-vars-headline="Exclusive: DecisionRx nets $100M credit facility from Carlyle" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.who.int/initiatives/medication-without-harm#:~:text=Unsafe%20medication%20practices%20and%20medication,at%20%2442%20billion%20USD%20annually." target="_blank">$42 billion annually </a>while health care spend <a class="gtmContentClick" data-vars-link-text="continues to increase" data-vars-click-url="https://www.healthsystemtracker.org/chart-collection/u-s-spending-healthcare-changed-time/#Total%20national%20health%20expenditures,%20US%20$%20Billions,%201970-2022" data-vars-content-id="e1678b9e-f9ce-430d-9505-cb8eef28f864" data-vars-headline="Exclusive: DecisionRx nets $100M credit facility from Carlyle" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.healthsystemtracker.org/chart-collection/u-s-spending-healthcare-changed-time/#Total%20national%20health%20expenditures,%20US%20$%20Billions,%201970-2022" target="_blank">continues to increase</a>.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

boulder

detroit

kansas-city

columbus

austin

dallas

atlanta

washington-dc

nw-arkansas

chicago

indianapolis

nashville

richmond

colorado-springs

houston

san-francisco

seattle

boston

des-moines

salt-lake-city

philadelphia

denver

phoenix

new-orleans

miami

twin-cities

raleigh

san-antonio

portland

san-diego

tampa-bay

cleveland

huntsville

pittsburgh

axios-local

axios-pro

axios-live

the-axios-show

Exclusive: DecisionRx nets $100M credit facility from Carlyle

What to read next